DIAGNOSTIC TEST 931
Properdin
Diagnostic test for Properdin. For the investigation of complement deficiency.
Indication
Investigation of complement deficiency. Properdin should always be analyzed in patients with meningococcal disease.
Method
The analysis is performed on plasma with addressable laser bead immunoassay (ALBIA).
Result
Results in serum are given as normal, elevated or lowered with a value in mg/L. Reference intervall: 11.4-23.1 mg/L.
Interpretation
Vid activation of the alternative pathway, properdin is consumed. Therefore, the properdin content can be used as a complement activation marker, especially in post-streptococcal nephritis and in sepsis. Hypocomplementemia with low properdin content in sepsis is a prognostically serious finding.
Included in these panels
Need pricing information?
How to order
This test is available worldwide for hospitals, clinics, and physicians.
-
Print and complete the request form
Download the request form. Clearly state the name and phone number of the referring hospital, clinic, or physician. -
Prepare your samples
EDTA Plasma: At least 0.5 mL blood plasma (EDTA tubes).
-
Send samples and request form
Within Sweden
Send samples frozen to:
Envelopes and smaller boxes:
Wieslab AB, Box 50117, 20211 Malmö, Sweden
Larger boxes and frozen samples:
Wieslab AB, Lundavägen 151, 21224 Malmö, Sweden
International
Send samples frozen to:
Wieslab AB, Lundavägen 151, 21224 Malmö, Sweden
Last updated: 2025-08-18
